A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer

Abstract Background Metastasis was the major cause of the high mortality in ovarian cancer. Although some mechanisms of metastasis in ovarian cancer were proposed, few have been targeted in the clinical practice. In the study, we aimed to identify novel genes contributing to metastasis and poor clin...

Full description

Bibliographic Details
Main Authors: Shuai Zong, Ping-ping Xu, Yin-hai Xu, Yi Guo
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-022-01024-x
_version_ 1797964678421282816
author Shuai Zong
Ping-ping Xu
Yin-hai Xu
Yi Guo
author_facet Shuai Zong
Ping-ping Xu
Yin-hai Xu
Yi Guo
author_sort Shuai Zong
collection DOAJ
description Abstract Background Metastasis was the major cause of the high mortality in ovarian cancer. Although some mechanisms of metastasis in ovarian cancer were proposed, few have been targeted in the clinical practice. In the study, we aimed to identify novel genes contributing to metastasis and poor clinical outcome in ovarian cancer from bioinformatics databases. Methods Studies collecting matched primary tumors and metastases from ovarian cancer patients were searched in the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were screened by software R language. Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis for the DEGs were implemented by Metascape. Venn diagram was plotted to present overlapping DEGs. The associations between the overlapping DEGs and prognosis were tested by Cox proportional hazard regression model using a cohort of ovarian cancer patients from the TCGA database. Genes affecting patients’ outcomes significantly were served as hub genes. The mechanisms of the hub genes in promoting ovarian cancer metastasis were then predicted by R software. Results Two gene expression profiles (GSE30587 and GSE73168) met the inclusion criteria and were finally analyzed. A total of 259 genes were significantly differentially expressed in GSE30587, whereas 712 genes were in GSE73168. In GSE30587, DEGs were mainly involved in extracellular matrix (ECM) organization; For GSE73168, most of DEGs showed ion trans-membrane transport activity. There were 9 overlapping genes between the two datasets (RUNX2, FABP4, CLDN20, SVEP1, FAM169A, PGM5, ZFHX4, DCN and TAS2R50). ZFHX4 was proved to be an independent adverse prognostic factor for ovarian cancer patients (HR = 1.44, 95%CI: 1.13–1.83, p = 0.003). Mechanistically, ZFHX4 was positively significantly correlated with epithelial-mesenchymal transition (EMT) markers (r = 0.54, p = 2.59 × 10−29) and ECM-related genes (r = 0.52, p = 2.86 × 10−27). Conclusions ZFHX4 might promote metastasis in ovarian cancer by regulating EMT and reprogramming ECM. For clinical applications, ZFHX4 was expected to be a prognostic biomarker for ovarian cancer metastasis.
first_indexed 2024-04-11T01:48:49Z
format Article
id doaj.art-73b90b20dcb54244a000a60d95b806b2
institution Directory Open Access Journal
issn 1757-2215
language English
last_indexed 2024-04-11T01:48:49Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj.art-73b90b20dcb54244a000a60d95b806b22023-01-03T07:22:25ZengBMCJournal of Ovarian Research1757-22152022-08-0115111410.1186/s13048-022-01024-xA bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancerShuai Zong0Ping-ping Xu1Yin-hai Xu2Yi Guo3Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical UniversityDepartment of Laboratory Medicine, Xuzhou Central HospitalDepartment of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical UniversityDepartment of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical UniversityAbstract Background Metastasis was the major cause of the high mortality in ovarian cancer. Although some mechanisms of metastasis in ovarian cancer were proposed, few have been targeted in the clinical practice. In the study, we aimed to identify novel genes contributing to metastasis and poor clinical outcome in ovarian cancer from bioinformatics databases. Methods Studies collecting matched primary tumors and metastases from ovarian cancer patients were searched in the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were screened by software R language. Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis for the DEGs were implemented by Metascape. Venn diagram was plotted to present overlapping DEGs. The associations between the overlapping DEGs and prognosis were tested by Cox proportional hazard regression model using a cohort of ovarian cancer patients from the TCGA database. Genes affecting patients’ outcomes significantly were served as hub genes. The mechanisms of the hub genes in promoting ovarian cancer metastasis were then predicted by R software. Results Two gene expression profiles (GSE30587 and GSE73168) met the inclusion criteria and were finally analyzed. A total of 259 genes were significantly differentially expressed in GSE30587, whereas 712 genes were in GSE73168. In GSE30587, DEGs were mainly involved in extracellular matrix (ECM) organization; For GSE73168, most of DEGs showed ion trans-membrane transport activity. There were 9 overlapping genes between the two datasets (RUNX2, FABP4, CLDN20, SVEP1, FAM169A, PGM5, ZFHX4, DCN and TAS2R50). ZFHX4 was proved to be an independent adverse prognostic factor for ovarian cancer patients (HR = 1.44, 95%CI: 1.13–1.83, p = 0.003). Mechanistically, ZFHX4 was positively significantly correlated with epithelial-mesenchymal transition (EMT) markers (r = 0.54, p = 2.59 × 10−29) and ECM-related genes (r = 0.52, p = 2.86 × 10−27). Conclusions ZFHX4 might promote metastasis in ovarian cancer by regulating EMT and reprogramming ECM. For clinical applications, ZFHX4 was expected to be a prognostic biomarker for ovarian cancer metastasis.https://doi.org/10.1186/s13048-022-01024-xZFHX4Ovarian cancerMetastasisEpithelial-mesenchymal transitionExtracellular matrix
spellingShingle Shuai Zong
Ping-ping Xu
Yin-hai Xu
Yi Guo
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer
Journal of Ovarian Research
ZFHX4
Ovarian cancer
Metastasis
Epithelial-mesenchymal transition
Extracellular matrix
title A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer
title_full A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer
title_fullStr A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer
title_full_unstemmed A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer
title_short A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer
title_sort bioinformatics analysis zfhx4 is associated with metastasis and poor survival in ovarian cancer
topic ZFHX4
Ovarian cancer
Metastasis
Epithelial-mesenchymal transition
Extracellular matrix
url https://doi.org/10.1186/s13048-022-01024-x
work_keys_str_mv AT shuaizong abioinformaticsanalysiszfhx4isassociatedwithmetastasisandpoorsurvivalinovariancancer
AT pingpingxu abioinformaticsanalysiszfhx4isassociatedwithmetastasisandpoorsurvivalinovariancancer
AT yinhaixu abioinformaticsanalysiszfhx4isassociatedwithmetastasisandpoorsurvivalinovariancancer
AT yiguo abioinformaticsanalysiszfhx4isassociatedwithmetastasisandpoorsurvivalinovariancancer
AT shuaizong bioinformaticsanalysiszfhx4isassociatedwithmetastasisandpoorsurvivalinovariancancer
AT pingpingxu bioinformaticsanalysiszfhx4isassociatedwithmetastasisandpoorsurvivalinovariancancer
AT yinhaixu bioinformaticsanalysiszfhx4isassociatedwithmetastasisandpoorsurvivalinovariancancer
AT yiguo bioinformaticsanalysiszfhx4isassociatedwithmetastasisandpoorsurvivalinovariancancer